The structures of two alkylurea inhibitors complexed with murine soluble epoxide hydrolase have been determined by x-ray crystallographic methods. The alkyl substituents of each inhibitor make extensive hydrophobic contacts in the soluble epoxide hydrolase active site, and each urea carbonyl oxygen accepts hydrogen bonds from the phenolic hydroxyl groups of Tyr 381 and Tyr 465 . These hydrogen bond interactions suggest that Tyr 381 and/or Tyr 465 are general acid catalysts that facilitate epoxide ring opening in the first step of the hydrolysis reaction; Tyr 465 is highly conserved among all epoxide hydrolases, and Tyr 381 is conserved among the soluble epoxide hydrolases. In one enzyme-inhibitor complex, the urea carbonyl oxygen additionally interacts with Gln 382 . If a comparable interaction occurs in catalysis, then Gln 382 may provide electrostatic stabilization of partial negative charge on the epoxide oxygen. The carboxylate side chain of Asp 333 accepts a hydrogen bond from one of the urea NH groups in each enzyme-inhibitor complex. Because Asp 333 is the catalytic nucleophile, its interaction with the partial positive charge on the urea NH group mimics its approach toward the partial positive charge on the electrophilic carbon of an epoxide substrate. Accordingly, alkylurea inhibitors mimic features encountered in the reaction coordinate of epoxide ring opening, and a structure-based mechanism is proposed for leukotoxin epoxide hydrolysis.
Epoxide hydrolases catalyze epoxide ring opening to produce 1,2-diol products (1, 2) . In mammals, these enzymes exist in two major forms: soluble epoxide hydrolase (sEH), 1 which is found in the cytosol and peroxisomal matrix, and microsomal epoxide hydrolase, which is membrane-anchored (1, 3, 4) . Both sEH and microsomal epoxide hydrolase are involved in the metabolism of numerous xenobiotics, and sEH also plays a crucial role in lipid epoxide homeostasis. For example, sEH catalyzes the hydrolysis of cis-9,10-epoxyoctadec-9(Z)-enoic acid (leukotoxin) to form its corresponding diol, threo-9,10dihydroxyoctadec-12(Z)-enoic acid (leukotoxin diol), and sEH similarly catalyzes the hydrolysis of cis-12,13-epoxyoctadec-9(Z)-enoic acid (isoleukotoxin) to form its corresponding diol threo-12,13-dihydroxyoctadec-9(Z)-enoic acid (isoleukotoxin diol) (5) ( Fig. 1 ). Leukotoxins can perturb membrane permeability and ion transport and cause inflammatory responses (5, 6) . Accordingly, sEH is a possible pharmaceutical target for the treatment of acute disorders such as multiple organ failure and adult respiratory distress syndrome (7) .
Recently, the crystal structure of native sEH was reported at 2.8 Å resolution (8) . The enzyme adopts a homodimeric, domain-swapped architecture in which the C-terminal domain belongs to the ␣/␤ hydrolase fold family (9, 10) . The C-terminal domain, or "catalytic domain," contains the active site residues required for epoxide hydrolysis. By analogy with related ␣/␤ hydrolases such as haloalkane dehalogenase (11) (12) (13) and in accord with labeling (14) and site-directed mutagenesis experiments (15, 16) , Asp 333 is the catalytic nucleophile that attacks the epoxide carbon in the first step of sEH catalysis. Asp 333 hydrogen bonds to His 523 , and this interaction may help to stabilize Asp 333 in the ionization state required for catalysis. The side chain of Asp 495 is close to His 523 , and a hydrogen bond may form between these two residues during catalysis. Given its active site location and absolute conservation among all sequenced epoxide hydrolases, Tyr 465 is a likely general acid that donates a proton to the epoxide oxygen in the first step of catalysis (8, 17) . The structure of native sEH also reveals that Tyr 381 is similarly located in the active site; being conserved among the sEH enzymes, this residue is likewise a candidate general acid (8, 17) . However, because Tyr 381 is not universally conserved among all epoxide hydrolases (it is apparently absent from the microsomal enzymes), it cannot be a universal general acid. The active site tunnel is L-shaped, with catalytic residues located at the corner of the L. Both ends of the L open to solvent; one end consists of a long, narrow hydrophobic channel, and the other end consists of a shorter, wider cleft containing a hydrophobic pocket. Although the N-terminal domain of sEH resembles other hydrolytic enzymes such as haloacid dehalogenase (18, 19) , this domain does not participate in epoxide hydrolysis, even though it contains an intact active site (8) .
Although the structures of native sEH enzymes from Agrobacterium radiobacter AD1 (17) , Aspergillus niger (20) , and murine (8) ʈ To whom correspondence should be addressed. Tel.: 215-898-5714; Fax: 215-573-2201; E-mail: chris@xtal.chem.upenn.edu. 1 The abbreviations used are: sEH, soluble epoxide hydrolase; mEH, microsomal epoxide hydrolase; CPU, N-cyclohexyl-NЈ-(3-phenylpropyl)urea; CDU, N-cyclohexyl-NЈ-decylurea; CIU, N-cyclohexyl-NЈ-(4iodophenyl)urea; r.m.s., root mean square. except for a single murine sEH-dialkylurea inhibitor complex (8) . Dialkylureas are potent inhibitors of the recombinant murine and human enzymes (7) , and the crystal structure of the murine sEH-N-cyclohexyl-NЈ-(3-phenyl)propylurea (CPU; K i ϭ 3.1 nM) complex reveals an unusual trans, cis-conformation for the dialkylurea moiety; inhibitor binding is stabilized by numerous hydrophobic van der Waals' contacts and a single hydrogen bond between Tyr 465 and a urea NH group (8) . Although the structure of the sEH-CPU complex confirmed the location of the sEH active site, it did not provide meaningful clues about substrate or transition state binding; the polarity of the single enzyme-inhibitor hydrogen bond was inconsistent with a potential function for Tyr 465 as a catalytic proton donor, and the known catalytic nucleophile Asp 333 did not contact the inhibitor. Thus, the mechanistic inferences from the first and only available structure of an sEH-inhibitor complex were quite limited. Could Tyr 381 or other polar residues in the sEH active site participate in inhibitor and/or substrate binding?
To clarify mechanistic inferences from the binding of potent alkylurea inhibitors to sEH, we now report the x-ray crystal structure determinations of sEH complexed with two different inhibitors: N-cyclohexyl-NЈ-decylurea (CDU; K i ϭ 6.3 Ϯ 0.5 nM) and N-cyclohexyl-NЈ-(4-iodophenyl)urea (CIU; K i ϭ 17 Ϯ 4 nM) ( Fig. 2 ). These inhibitors bind in the sEH active site and directly mimic interactions consistent with the activation of a substrate epoxide ring for nucleophilic attack by Asp 333 .
EXPERIMENTAL PROCEDURES
Inhibitor Syntheses-To a stirred solution of 0.60 ml (0.47 g, 3.0 mmol) of decylamine in 20 ml of hexane was added 0.38 ml (0.37 g, 3.0 mmol) of cyclohexylisocyanate, which produced a white crystalline solid. After standing overnight the mixture was cooled, and the solid product was collected, washed with cold hexane, and dried to obtain 0.776 g (2.75 mmol, 92%) of CDU as a white powder, mp 88.5-89.5°C: IR (KBr) 3345 (m, NH), 3318 (m, NH), 1624 (versus, CϭO), 1578 (s, amide II) cm Ϫ1 ; 1 H NMR (300.1 MHz, CDCl 3 ) ␦ 4.2 (m, 2 H, 2 NH), 3.5 (m, 1 H, CH-1), 3.13 (dt, J ϭ 6.0, 6.8 Hz, 2 H, CH 2 -1Ј), 1.9 (m, 2 H), 1.0 -1.8 (m, 24 H), 0.88 (t, J ϭ 6.9 Hz, 3 H, CH 3 ); 13 (7), yielding K i ϭ 6.3 Ϯ 0.5 nM.
A solution of 1.10 g (5.00 mmol) of 4-iodoaniline and 0.688 g (5.50 mmol) of cyclohexylisocyanate in 25 ml of ether kept in the dark at ambient temperature, deposited 0.591 g of CIU after 1 week. Recrystallization of the solid from methanol after treatment with Norite produced 0.332 g (20%) of white needles, mp 246.5-247.5°C. After one month, the above filtrate, when evaporated to dryness, and the residue recrystallized from ethanol provided another 0.580 g of product as white needles, mp 246.5-247.5°C, for a total yield of 55%. TLC (0. (7), yielding K i ϭ 17 Ϯ 4 nM.
Crystallization and Structure Determination-Crystals of sEH were prepared as described (8), and the sEH-CDU and sEH-CIU complexes were prepared in crystal soaking experiments. Briefly, CDU and CIU were dissolved to concentrations of 100 mM in 100% ethanol and Me 2 SO, respectively. 1 l of each stock solution was added in sitting drop wells containing 100 l of mother liquor. The sEH crystals were transferred to these wells and soaked in the 1 mM inhibitor solution for 4 days. Crystals were flash-cooled following the addition of 30% glycerol to the mother liquor (v/v).
Diffraction data were collected at Cornell High Energy Synchrotron Source at a wavelength of 0.890 Å at 100 K. Diffraction intensities were measurable to 3.0 -3.1 Å resolution. Crystals of each complex were isomorphous with those of the native enzyme and belong to spacegroup P2 1 2 1 2, a ϭ 151.9 Å, b ϭ 143.0 Å, c ϭ 60.0 Å. Data reduction and integration was achieved with DENZO and SCALEPACK (21) . Initial ͉F o ͉ Ϫ ͉F c ͉ and 2͉F o ͉ Ϫ ͉F c ͉ electron density maps were generated with structure factors calculated from the native sEH structure using routines in CCP4 and X-PLOR (22, 23) . Initial refinement was achieved with X-PLOR (23). After positional refinement, simulated annealing minimizations (T inital ϭ 3000 K), and individual B factor refinement, both inhibitors were modeled into unbiased ͉F o ͉ Ϫ ͉F c ͉ electron density (24) . Inhibitor molecules were created, and their conformations were energy-minimized using the program INSIGHT (25) . In the last cycles of refinement, waters were added using WATPEAK (22) , and their positions were refined with X-PLOR (23). Both inhibitors were bound to the C-terminal domains of each monomer. As in the native structure, the N-terminal Met 1 -Leu 3 and the C-terminal Val 545 -Ile 554 segments were not modeled because of disorder in both monomers; additionally, Ala 20 -Glu 47 and Val 64 -Ser 89 were disordered in monomer A. Refinement statistics are recorded in Table I .
RESULTS AND DISCUSSION
Although the resolution of these enzyme-inhibitor complexes is considered modest at 3.0 -3.1 Å, the information content of these structures is nevertheless quite high. The binding conformations of CDU and CIU are determined unambiguously, and these conformations are quite similar; that similar conformations are observed in two independent experiments with two independent inhibitors strengthens the interpretation of intermolecular interactions despite the modest resolution. Importantly, the intermolecular interactions of CDU and CIU provide the first glimpse of a constellation of hydrogen bonds that activate epoxide substrates for hydrolysis, and these interactions were not observed in the previously determined structure of the sEH-CPU complex (8) . The discussion below outlines the structures of the sEH-CDU and sEH-CIU complexes and then incorporates this new structural information into a brief discussion of substrate specificity and a proposed mechanism for the hydrolysis of complex epoxide substrates.
Inhibitor Binding Modes-The binding of CDU does not trigger any significant tertiary or quaternary structural changes in sEH, as indicated by the r.m.s. deviation of 0.4 Å for 994 C␣ atoms between the native enzyme and the enzyme-inhibitor complex. However, some local structural changes are observed in the active site that may reflect possible binding interactions of larger epoxide substrates such as the leukotoxins. The inhibitor binds with a trans,trans dialkyl urea linkage, and the NЈ-decyl tail extends out of the active site and makes numerous van der Waals' contacts with hydrophobic residues such as Met 361 , Val 372 , Trp 334 , Val 337 , and Pro 363 (Fig. 3 ). Thermal B factors increase toward the end of the decyl tail of CDU, which may indicate increased flexibility in substrate binding toward the end of the active site tunnel. The N-cyclohexyl group packs in the hydrophobic pocket and makes numerous van der Waals' contacts with hydrophobic residues Val 497 , Phe 406 , Phe 265 , Trp 524 , and Tyr 381 .
Significantly, the urea carbonyl group accepts hydrogen bonds from Tyr 465 and Tyr 381 . Tyr 465 is a conserved residue in the epoxide hydrolase family and is a proposed general acid in catalysis (8, 17) . Although Tyr 381 is not conserved in the microsomal epoxide hydrolases, it is also considered a possible general acid catalyst (8, 17) . Recent experiments show that mutation of Tyr 381 and Tyr 465 to phenylalanine individually and together dramatically reduces catalytic activity, particularly with chemically stable substrates; notably, catalytic activity in the double variant is completely eliminated. 2 Likewise, site-directed mutagenesis studies of the epoxide hydrolase from A. radiobacter AD1 indicate that both of the corresponding tyrosine residues are important for catalysis (26) . Therefore, both x-ray crystallography and site-directed mutagenesis together indicate that Tyr 381 and Tyr 465 serve as general acid catalysts that activate the substrate epoxide ring for nucleo- philic atack by Asp 333 . Interestingly, Asp 333 accepts a hydrogen bond from the urea NH group of CDU, which may mimic the interaction between the catalytic nucleophile and the partial positive charge on the substrate epoxide carbon.
Another polar active site residue may play a role in the hydrolysis reaction. The side chain of Gln 382 undergoes a conformational change and moves closer to the bound inhibitor, donating an additional hydrogen bond to the urea carbonyl group. Because Gln 382 is conserved among the mammalian isozymes, it is possible that this residue is an electrostatic catalyst that helps to stabilize the epoxide oxygen in catalysis by hydrogen bonding.
As in the sEH-CDU complex, the binding of CIU does not trigger any major tertiary or quaternary structural changes in sEH, as indicated by the r.m.s deviation of 0.5 Å for 994 C␣ atoms between the native enzyme and the enzyme-inhibitor complex. Nevertheless, some local structural changes in the active site accommodate inhibitor binding. The inhibitor binds with a trans,trans-dialkyl linkage, and the cyclohexyl ring packs in the hydrophobic pocket, making van der Waals' contacts with Val 497 , Phe 406 , Phe 265 , Trp 524 , and Tyr 381 (Fig. 4) . Interestingly, the cyclohexyl ring of CIU adopts a different conformation with respect to the urea group, corresponding to a 58°rotation about the C-N linkage; this is visible in the superposition of Fig. 5 . This reflects the large size of the hydrophobic pocket that can accommodate large substrate substituents and different conformations of such substituents in this region of the active site. The iodophenyl group of CIU binds in the hydrophobic channel, making van der Waals' contacts with Trp 334 , Leu 498 , Met 361 , and Val 337 (Fig. 4) . Because both CDU and CIU bind with trans,trans-dialkylurea linkages and CPU binds with an unusual trans,cis-dialkylurea linkage (8), we advance that the binding mode of CPU is probably exceptional and not preferential for this series of inhibitors (7) .
There is no indication of "backwards" binding of the inhibitor, because the position of the inhibitor iodine atom in each catalytic domain is confirmed by 12 peaks in omit electron density maps (data not shown). As observed in the sEH-CDU complex, the carbonyl group of CIU accepts hydrogen bonds from Tyr 465 and Tyr 381 ; however, it does not interact with Gln 382 , even though Gln 382 undergoes a small conformational change. Finally, Asp 333 accepts a hydrogen bond from the urea NH group of CIU. The common binding modes of both inhibitors in the sEH active site are clearly visible in the superposition of Fig. 5 .
Structural Inferences on Substrate Specificity-With only three or four intermolecular hydrogen bond interactions made in each enzyme-inhibitor complex, the substrate binding conformation is mostly governed by van der Waals' contacts made with the residues defining the unique active site contour. The binding modes of CDU and CIU show how sEH accommodates large aliphatic substrates such as the leukotoxins. As mentioned previously, the active site is in the middle of a hydrophobic, L-shaped tunnel. The long, aliphatic inhibitor CDU conforms to this hydrophobic L-shaped contour, and corresponding substrate binding modes can be postulated based on the structure of the sEH-CDU complex (Fig. 6 ). The specificity of sEH will be greatest toward the larger aliphatic substrates that can achieve favorable binding conformation in the L-shaped tunnel; presumably, substrate binding modes in which epoxide substituents dangle out of one end of the active site tunnel would be disfavored.
Introduction of multiple degrees of unsaturation in the substrate can possibly hinder substrate binding, or may alter regiochemical preferences for the nucleophilic attack of Asp 333 at one or the other epoxide carbon. For example, in the hydrolysis of cis-epoxyeicosatrienoic acids, optimal sEH activity favors the 14(R),15(S)-epoxide rather than the 14(S),15(R) stereoisomer or the 5,6-, 8,9-, or 11,12-epoxide isomers (27, 28) . The cis-epoxyeicosatrienoic acids have significant conformational restraints imposed upon binding because of their unsaturation. Apparently, only the 14(R),15(S)-epoxide isomer can achieve an optimal substrate binding conformation in the Lshaped active site tunnel of sEH. Moreover, preferential formation of the vic-dihydroxyeicosatrienoic acid product with 14(R),15(R) stereochemistry indicates a regiochemical preference for nucleophilic attack of Asp 333 at C-15 of the 14(R),15(S)cis-epoxyeicosatrienoic acid substrate (27, 28) .
Mechanistic Inferences from Inhibitor Binding-Previous structural and biochemical evidence suggest that sEH catalysis proceeds through an S N 2-like reaction at the substrate epoxide carbon (8, 14 -16) . The epoxide moiety displays partial positive charges on each carbon and a partial negative charge on the oxygen, and the distribution of partial charge in the reaction coordinate of epoxide ring opening is mimicked by the dialkylurea inhibitors CDU and CIU (Fig. 2) . From the hydrogen bond interactions observed in the sEH-CDU and sEH-CIU complexes it is inferred that the carboxylate group of Asp 333 per-forms a backside nucleophilic attack on the electrophilic epoxide carbon in concert with proton donation to the epoxide oxygen by Tyr 465 or Tyr 381 . Each tyrosine hydroxyl group is oriented nearly perfectly in-line with a lone electron pair on the epoxide oxygen when the epoxide is aligned for nucleophilic attack by Asp 333 (Fig. 7) . Therefore, the constellation of interactions with Asp 333 , Tyr 465 , and Tyr 381 define the reaction coordinate of the first step of catalysis. Possible hydrogen bond interactions with Gln 382 may mimic additional polar interactions that stabilize the transition state.
In conclusion, the mechanism of leukotoxin hydrolysis outlined in Fig. 8 incorporates the new structural information emanating from the sEH-CDU and sEH-CIU complexes, and this mechanism is representative for the hydrolysis of a lipid epoxide substrate. The carboxylate side chain of Asp 333 is the catalytic nucleophile that attacks the electrophilic carbon of the epoxide. Directly across the active site cavity from Asp 333 are the phenolic side chains of Tyr 465 and Tyr 381 , one of which can serve as a proton donor to activate and accelerate epoxide ring opening. The tyrosine that does not donate its proton can nevertheless serve as an electrostatic catalyst, along with Gln 382 , by hydrogen bond donation to the epoxide oxygen. Parenthetically, we note that Tyr 465 is flanked by edge-to-face interactions with Trp 334 and Phe 385 that would stabilize the intermediate phenolate anion; no such interactions can be achieved by the phenolate anion of Tyr 381 , but this does not rule out Tyr 381 as a proton donor. The alkylenzyme ester intermediate is subsequently hydrolyzed by a water molecule promoted by general base His 523 . The basicity of His 523 is likely enhanced by the negatively charged carboxylate side chain of Asp 495 and the partial negative charge of the indole ring of Trp 524 ; the imidazole ring makes a classic cation-interaction with Trp 524 . Finally, an "oxyanion hole" containing backbone NH groups of Phe 265 
